On August 27, 2020, Nix Patterson and Co-Counsel Ryan Whaley obtained a final judgment following the verdict of more than $150 million on behalf of Oklahoma royalty owners. The Honorable Judge John Gibney, sitting by designation in the Eastern District of Oklahoma, ruled in favor of the Plaintiff, Perry Cline, and the Class of owners
News Attorney Category: Trey Duck
Nix Patterson and Ryan Whaley Win Record Setting Oklahoma Class Action Verdict
On August 17, 2020, Nix Patterson and Co-Counsel Ryan Whaley obtained a verdict of more than $150 million on behalf of Oklahoma royalty owners. The Honorable Judge John Gibney, sitting by designation in the Eastern District of Oklahoma, ruled in favor of the Plaintiff, Perry Cline, and the Class of owners he represented following a
Nix Patterson and Whitten Burrage File Lawsuits on behalf of Oklahoma Against Opioid Distributors
On May 1, 2020, Nix Patterson and Co-Counsel Whitten Burrage filed three lawsuits on behalf of the State of Oklahoma against opioid distributors McKesson, Amerisource Bergen, and Cardinal Health. The firms filed the three separate lawsuits in Bryan County. The lawsuits allege the defendants ignored their duties and responsibilities to prevent oversupply and diversion of
Trey Duck and Drew Pate Elected Partners
Nix Patterson, LLP is pleased to announce that Trey Duck and Drew Pate have been elected partners. Drew started at the firm in 2011, and Trey joined in 2012. Throughout their careers, both have worked for the firm’s complex commercial litigation team, which handles class actions, oil and gas litigation, securities fraud, qui tam cases, and state
Nix Patterson Wins 2019 Trial Team of the Year for Opioids Trial
Nix Patterson has been named the 2019 Trial Team of the Year by The National Trial Lawyers in recognition of the firm’s $465 million verdict against opioid manufacturer Johnson & Johnson. Nix Patterson, along with co-counsel Whitten Burrage, represented the State of Oklahoma in its historic litigation against the manufacturers of addictive opioid pain medications.
Nix Patterson Wins Historic Judgment for Oklahoma in Nation’s First Opioid Trial
Norman, Oklahoma – Today, Judge Thad Balkman ruled in favor of the State of Oklahoma in the nation’s first opioid trial, requiring defendant Johnson & Johnson and its subsidiary Janssen to pay $572,102,028 into a fund that will be used to remedy the devastating public nuisance in Oklahoma. Nix Patterson, LLP represented Oklahoma throughout the
Nix Patterson & Whitten Burrage Begin Historic Trial in Oklahoma Opioid Litigation
See Law360 Article below: “Meet The Attorneys Facing Off In The Oklahoma Opioid Trial” Please note: After publication of this article, the Teva Defendants entered into a settlement agreement with the State of Oklahoma for $85 Million.
Nix Patterson and Whitten Burrage Obtain Historic $270 Million Settlement with Purdue Pharma in Oklahoma Opioid Litigation
On March 26, 2019, the State of Oklahoma announced that one of the defendants in litigation against several manufacturers of opioid-based painkillers, Purdue Pharma, had agreed to pay $270 million to settle the claims brought against it by the State of Oklahoma and Oklahoma Attorney General Mike Hunter. The State alleged Purdue aggressively marketed its
Oklahoma Supreme Court Rejects Big Pharma’s Request to Delay Trial in Oklahoma Opioid Litigation
On March 25, 2019, the Oklahoma Supreme Court denied a request by Defendant drugmakers to delay the start of the first state lawsuit against opioid manufacturers to go to trial. Cleveland County District Court Judge Thad Balkman previously rejected the delay request, saying the matter is of huge public importance and should move forward in
Oklahoma Attorney General Says Defendant in Oklahoma Opioid Litigation, Johnson & Johnson, Acted as Opioid “Kingpin”
In a February 26th filing in Cleveland County District Court, Oklahoma Attorney General Mike Hunter alleged that Johnson & Johnson acted as an opioid “kingpin” by using a web of foreign and domestic subsidiaries to supply raw materials “necessary to manufacture the opioid pain medications thrust upon the unsuspecting public since the 1990s.” In the